Testosterone Prescribing in Texas, 2018-2021

Affiliations

¹ Department of Internal Medicine, University of Texas at Austin Dell Medical School, 1601 Trinity St., Austin, TX, 78712, USA. scott.selinger@austin.utexas.edu.
² University of Texas at Austin Dell Medical School, 1501 Red River St., Austin, TX, 78712, USA.
³ Pharmacotherapy Education & Research Center, School of Medicine, University of Texas Health San Antonio, 7703 Floyd Curl Drive, MC 6220, San Antonio, TX, 78229-3900, USA.

Scott Selinger et al. J Gen Intern Med. 2023 Nov.

. 2023 Nov;38(15):3436-3438.

doi: 10.1007/s11606-023-08316-y.

¹ Department of Internal Medicine, University of Texas at Austin Dell Medical School, 1601 Trinity St., Austin, TX, 78712, USA. scott.selinger@austin.utexas.edu.
² University of Texas at Austin Dell Medical School, 1501 Red River St., Austin, TX, 78712, USA.
³ Pharmacotherapy Education & Research Center, School of Medicine, University of Texas Health San Antonio, 7703 Floyd Curl Drive, MC 6220, San Antonio, TX, 78229-3900, USA.

No abstract available

Figures

1. Baillargeon J, Kuo YF, Westra JR, Urban RJ, Goodwin JS. Testosterone Prescribing in the United States, 2002-2016. JAMA. 2018;320(2):200–202. doi: 10.1001/jama.2018.7999. - DOI - PMC - PubMed
1. de Dios C, Fernandes BS, Whalen K, Bandewar S, Suchting R, Weaver MF, Selvaraj S. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2021;229(Pt A):109176. doi: 10.1016/j.drugalcdep.2021.109176. - DOI - PMC - PubMed
1. Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023. 10.1056/NEJMoa2215025. Epub ahead of print.
1. Walker RF, Zakai NA, MacLehose RF, Cowan LT, Adam TJ, Alonso A, Lutsey PL. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med. 2020;180(2):190–197. doi: 10.1001/jamainternmed.2019.5135. - DOI - PMC - PubMed
1. Morden NE, Woloshin S, Brooks CG, Schwartz LM. Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease. JAMA Intern Med. 2019;179(3):446–448. doi: 10.1001/jamainternmed.2018.6505. - DOI - PMC - PubMed